MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $340 | -12.6% | 2,327 | +38.3% | 0.03% | -16.1% |
| Q2 2023 | $389 | +0.5% | 1,683 | +5.3% | 0.03% | +10.7% |
| Q1 2023 | $387 | -75.9% | 1,599 | -71.1% | 0.03% | -79.1% |
| Q4 2022 | $1,606 | -99.5% | 5,532 | +21.9% | 0.13% | +396.3% |
| Q3 2022 | $295,000 | +15.2% | 4,538 | +27.1% | 0.03% | +17.4% |
| Q2 2022 | $256,000 | +12.3% | 3,570 | +53.7% | 0.02% | +228.6% |
| Q1 2022 | $228,000 | – | 2,322 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |